Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe status of a clinical trial has been updated to 'Unknown' and is now verified by the University of Kansas Medical Center, indicating a change in its recruitment status.SummaryDifference0.7%
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study descriptions and eligibility criteria for a clinical trial on adenocarcinoma of the gastroesophageal junction and stomach, while adding a new version number and collaborators.SummaryDifference48%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.